Advanced search
Publication Cover
Experimental Lung Research Volume 5, 1983 - Issue 3
Submit an article Journal homepage
13
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Abnormal Alveolar Cells in Monocrotaline Induced Pulmonary Hypertension

T. Sugita CVP Research Laboratory, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, Colorado, B-133
,
K. R. Stenmark CVP Research Laboratory, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, Colorado, B-133
,
W. W Wagner CVP Research Laboratory, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, Colorado, B-133
,
P. M. Henson CVP Research Laboratory, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, Colorado, B-133
,
J. E. Henson CVP Research Laboratory, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, Colorado, B-133
,
T. M. Hyers CVP Research Laboratory, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, Colorado, B-133
&
J. T. Reeves National Jewish Hospital, 3800 East Colfax, Denver, Colorado
 show all
Pages 201-215 | Received 28 Jan 1983, Accepted 20 Apr 1983, Published online: 02 Jul 2009

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

A. E. Schultze & R. A. Roth. (1998) Chronic pulmonary hypertension‐the monocrotaline model and involvement of the hemostatic system. Journal of Toxicology and Environmental Health, Part B 1:4, pages 271-346.
Read now
Heidi Foth. (1995) Role of the Lung in Accumulation and Metabolism of Xenobiotic Compounds — Implications for Chemically Induced Toxicity. Critical Reviews in Toxicology 25:2, pages 165-205.
Read now
James A. Burbach, Thomas A. Langworthy, Evelyn H. Schlenker & Phyllis M. Frost-Stotz. (1985) Lipidosis of Pulmonary Macrophages in the Dystrophic Hamster. Experimental Lung Research 9:1-2, pages 99-117.
Read now

Articles from other publishers (25)

Young Mi HongJung Hyun KwonShinkyu ChoiKwan Chang Kim. (2014) Apoptosis and Inflammation Associated Gene Expressions in Monocrotaline-Induced Pulmonary Hypertensive Rats after Bosentan Treatment. Korean Circulation Journal 44:2, pages 97.
Crossref
Soban Umar, Marlene Rabinovitch & Mansoureh Eghbali. (2012) Estrogen Paradox in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine 186:2, pages 125-131.
Crossref
A. Charlotte P. SewingCrystal KantoresJulijana IvanovskaAlvin H. LeeAzhar Masood, Amish Jain, Patrick J. McNamara, A. Keith Tanswell & Robert P. Jankov. (2012) Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α. American Journal of Physiology-Lung Cellular and Molecular Physiology 303:1, pages L75-L87.
Crossref
Wakana Nakayama, Masatoshi Jinnin, Katsunari Makino, Ikko Kajihara, Takamitsu Makino, Satoshi Fukushima, Yuji Inoue & Hironobu Ihn. (2010) Serum levels of soluble CD163 in patients with systemic sclerosis. Rheumatology International 32:2, pages 403-407.
Crossref
Pravin B. Sehgal & Jason E. Lee. (2011) Protein Trafficking Dysfunctions: Role in the Pathogenesis of Pulmonary Arterial Hypertension. Pulmonary Circulation 1:1, pages 17-32.
Crossref
Paul Jurasz, David Courtman, Saeid Babaie & Duncan J. Stewart. (2010) Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials. Pharmacology & Therapeutics 126:1, pages 1-8.
Crossref
R. Naeije & L. Dewachter. (2007) Modèles animaux d’hypertension artérielle pulmonaire. Revue des Maladies Respiratoires 24:4, pages 481-496.
Crossref
Kazuyo Yamaji-Kegan, Qingning Su, Daniel J. Angelini, Hunter C. Champion & Roger A. Johns. (2006) Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. American Journal of Physiology-Lung Cellular and Molecular Physiology 291:6, pages L1159-L1168.
Crossref
Somshuvra Mukhopadhyay, Mehul Shah, Kirit Patel & Pravin B. Sehgal. (2006) Monocrotaline pyrrole-induced megalocytosis of lung and breast epithelial cells: Disruption of plasma membrane and Golgi dynamics and an enhanced unfolded protein response. Toxicology and Applied Pharmacology 211:3, pages 209-220.
Crossref
Robin Kamal, Agostino Molteni, Mikhail Zoubine, Maxim Norkin, Sara Reppert, Yuan Xue, Richard Baybutt, Betty L.R. Herndon & Alex Shnyra. (2004) Diet high in retinoic acid controls M1/M2 activation phenotypes in macrophages and protects from monocrotaline-induced pulmonary fibrosis. Nutrition Research 24:10, pages 773-785.
Crossref
Mei-Jung Chen & Yih-Loong Lai. (2003) Tachykinin dysfunction attenuates monocrotaline-induced pulmonary hypertension. Toxicology and Applied Pharmacology 187:3, pages 178-185.
Crossref
Yasuhiro IkedaYoshikazu YonemitsuChu Kataoka, Shiro Kitamoto, Terutoshi Yamaoka, Ken-Ichi Nishida, Akira Takeshita, Kensuke Egashira & Katsuo Sueishi. (2002) Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats. American Journal of Physiology-Heart and Circulatory Physiology 283:5, pages H2021-H2028.
Crossref
Robert P Jankov, Xiaoping Luo, Rosetta Belcastro, Ian Copland, Helena Frndova, Stephen J Lye, John R Hoidal, Martin Post & A Keith Tanswell. (2001) Gadolinium Chloride Inhibits Pulmonary Macrophage Influx and Prevents O2-Induced Pulmonary Hypertension in the Neonatal Rat. Pediatric Research 50:2, pages 172-183.
Crossref
KAZUSHIGE OKADA, MATTHEW L. BERNSTEIN, WEI ZHANG, DANIEL P. SCHUSTER & MITCHELL D. BOTNEY. (1998) Angiotensin-converting Enzyme Inhibition Delays Pulmonary Vascular Neointimal Formation. American Journal of Respiratory and Critical Care Medicine 158:3, pages 939-950.
Crossref
Kuen-Shan Hung & William H. Duncan. (2020) Effects of Nitric Oxide on Monocrotaline Induced Right Ventricular Hypertrophy and Lung Mast Cell Hyperplasia in Rats. Microscopy and Microanalysis 4:S2, pages 1072-1073.
Crossref
RYAN J. HUXTABLE. 1993. Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells. Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells 213 237 .
M.K. Carruth, A.A. Fowler, R.P. Fairman, D.J. Mayer & G.R. Leichnetz. (1992) Respiratory failure without pulmonary edema following injection of a glutamate agonist into the ventral medullary raphe of the rat. Brain Research Bulletin 28:3, pages 365-378.
Crossref
S. Ono & N. F. Voelkel. (1992) PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model. Lung 170:1, pages 31-40.
Crossref
Lester C. Pan, Michael W. Lam?Dexter Morin, Dennis W. Wilson & H.J. Segall. (1991) Red blood cells augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem liver and lung preparations. Toxicology and Applied Pharmacology 110:2, pages 336-346.
Crossref
A.E. Schultze, J.G. Wagner, S.M. White & R.A. Roth. (1991) Early indications of monocrotaline pyrrole-induced lung injury in rats. Toxicology and Applied Pharmacology 109:1, pages 41-50.
Crossref
Ryan J. Huxtable. (1990) Activation and pulmonary toxicity of pyrrolizidine alkaloids. Pharmacology & Therapeutics 47:3, pages 371-389.
Crossref
Lydia Vincic, F.William Orr, Deborah J.A. Warner, Kaye L. Suyama & J.Michael Kay. (1989) Enhanced cancer metastasis after monocrotaline-induced lung injury. Toxicology and Applied Pharmacology 100:2, pages 259-270.
Crossref
R IlkiwL Todorovich-HunterK MaruyamaJ ShinM Rabinovitch. (1989) SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.. Circulation Research 64:4, pages 814-825.
Crossref
Mark N. Gillespie, Jack W. Olson, Bernhard Hennig, Donald A. Cohen, Craig J. McClain & Simeon E. Goldblum. (1989) Monokine-induced lung injury in rats: Similarities to monocrotaline-induced pneumotoxicity. Toxicology and Applied Pharmacology 98:1, pages 134-143.
Crossref
J. MICHAEL KAY. 1987. The Pulmonary Circulation in Health and Disease. The Pulmonary Circulation in Health and Disease 41 56 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.